Bunnage Mark E.

Insider profile

Bunnage Mark E.'s trades of Vertex Pharmaceuticals Incorporated's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-19 2026-05-15
PlS Planned sale
40,561 +7.7%
118.58
US$3,812,861 		40,561 +7.7% 118.58 US$3,812,861
2026-05-15 2026-05-15
PrS Proposed sale
99,738
22.89
US$542,017 		99,738 22.89 US$542,017
2026-02-26 2026-02-25
PlS Planned sale
14,375 +31.8%
489.73
US$2,407,033 		14,375 +31.8% 489.73 US$2,407,033
2026-02-25 2026-02-25
PrS Proposed sale
620
486.35
US$301,537 		620 486.35 US$301,537
2026-02-19 2026-02-18
PlS Planned sale
1,182 -12.2%
473.68
US$559,890 		1,182 -12.2% 473.68 US$559,890
2026-02-18 2026-02-18
PrS Proposed sale
1,182
473.68
US$559,890 		1,182 473.68 US$559,890
2026-02-19 2026-02-17
PlS Planned sale
2,437 -20.1%
489.46
US$1,192,814 		2,437 -20.1% 489.46 US$1,192,814
2026-02-17 2026-02-17
PrS Proposed sale
2,437
489.46
US$1,192,814 		2,437 489.46 US$1,192,814
2026-02-12 2026-02-11
PlS Planned sale
2,021 -13.5%
460.43
US$930,529 		2,021 -13.5% 460.43 US$930,529
2026-02-11 2026-02-11
PrS Proposed sale
2,021
460.43
US$930,529 		2,021 460.43 US$930,529